businesswire.com · 15 jul

Bruker Expands Infection Detection Portfolio with Acquisition of Metagenomic mNGS DISQVER® Platform for Pathogenic Microorganisms in Blood

BREMEN, Germany--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of the DISQVER® clinical metagenomics platform from Noscendo GmbH.DISQVER® enables metagenomic next-generation sequencing (mNGS) analysis of microbes directly from blood samples, further expanding Bruker's NGS-based infection detection capabilities. Without any need for prior cultivation, DISQVER analyzes whole genome sequencing (WGS) data and applies advanced, proprietary bioinformatics to search.

zacks.com · 19 jun

Bruker Gains 50.3% in a Year: What's Driving the Rally?

BRKR's rally is fueled by BSI NANO growth, AI-driven metrology demand and gains in preclinical imaging despite tariff pressures.

forbes.com · 17 jun

The Healthcare M&A Wave

In this week's edition of InnovationRx, we look at biotech M&A, the rise of India's Anthem Biosciences, and more. To get it in your inbox, subscribe here.

gurufocus.com · 15 jun

Bruker Corp (BRKR) Stock Up 4.4% and Still Undervalued -- GF Score: 85/100

On June 15, 2026, Bruker Corp (BRKR) shares rose 4.4% to a current price of $56.63. The stock has shown remarkable performance within the past year, with a 48.7

seekingalpha.com · 8 jun

Bruker Corporation (BRKR) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Bruker Corporation (BRKR) Presents at Jefferies Global Healthcare Conference 2026 Transcript

marketbeat.com · 6 jun

Bruker Signals Growth Pivot as Semiconductor and Overseas Orders Gain Steam

Bruker NASDAQ: BRKR is seeing stronger order momentum across several end markets, with semiconductor metrology, non-U.S. academic and government customers, and parts of its diagnostics business helping offset continued weakness in U.S. academic funding, a company representative said at a Jefferies healthcare conference.

zacks.com · 5 jun

Bruker (BRKR) Up 37.1% Since Last Earnings Report: Can It Continue?

Bruker (BRKR) reported earnings 30 days ago. What's next for the stock?

fool.com · 4 jun

State Street SPDR S&P Pharmaceuticals vs First Trust NYSE Arca Biotech: Which Is the Better ETF For Your Portfolio?

Explore how these two healthcare ETFs differ in diversification, sector focus, and portfolio concentration-key factors shaping their long-term investor appeal.